Broxyquinoline

Overview

Broxyquinoline (Dibromohydroxyquinoline) is an effective inhibitor of severe fever with thrombocytopenia syndrome virus ( SFTSV ) with an IC 50 of 5.8 µM. Additionally, Broxyquinoline is an inhibitor of CpACBP 1 with an IC 50 of 64.9 μM. CpACBP 1 is a fatty acyl-CoA binding protein of Cryptosporidium parvum , thus Broxyquinoline has the potential to inhibit parasite growth. Broxyquinoline shows promise for research in the field of infectious diseases.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Parasitic Infection | Products > Disease Areas > Blood Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Parasite | Products > Signaling Pathways > Influenza Virus

Product Information

• Catalog No.: HY-B1212
• CAS No.: 521-74-4
• Molecular Formula: C9H5Br2NO
• Molecular Weight: 302.95
• Purity: 99.74%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 2.08 mg/mL (6.87 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source